{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T21:48:00Z","timestamp":1767649680659,"version":"build-2065373602"},"reference-count":74,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart Failure Clinics"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.hfc.2019.08.007","type":"journal-article","created":{"date-parts":[[2019,11,14]],"date-time":"2019-11-14T17:09:21Z","timestamp":1573751361000},"page":"107-120","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Atrial Fibrillation in Heart Failure"],"prefix":"10.1016","volume":"16","author":[{"given":"Mohammed","family":"Obeidat","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Malcolm","family":"Burgess","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory Y.H.","family":"Lip","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.hfc.2019.08.007_bib1","doi-asserted-by":"crossref","first-page":"7","DOI":"10.15420\/cfr.2016:25:2","article-title":"Global public health burden of heart failure","volume":"3","author":"Savarese","year":"2017","journal-title":"Card Fail Rev"},{"issue":"18","key":"10.1016\/j.hfc.2019.08.007_bib2","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1161\/CIRCULATIONAHA.108.821306","article-title":"Atrial fibrillation and heart failure: treatment considerations for a dual epidemic","volume":"119","author":"Anter","year":"2009","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.hfc.2019.08.007_bib3","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1161\/01.CIR.0000140263.20897.42","article-title":"Lifetime risk for development of atrial fibrillation: the Framingham Heart Study","volume":"110","author":"Lloyd-Jones","year":"2004","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.hfc.2019.08.007_bib4","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.chest.2017.10.001","article-title":"Lifetime risks, projected numbers, and adverse outcomes in asian patients with atrial fibrillation: a report from the Taiwan Nationwide AF cohort study","volume":"153","author":"Chao","year":"2018","journal-title":"Chest"},{"issue":"7","key":"10.1016\/j.hfc.2019.08.007_bib5","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1160\/TH16-11-0876","article-title":"Stroke prevention in atrial fibrillation: past, present and future. Comparing the guidelines and practical decision-making","volume":"117","author":"Lip","year":"2017","journal-title":"Thromb Haemost"},{"issue":"2","key":"10.1016\/j.hfc.2019.08.007_bib6","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1161\/01.STR.32.2.392","article-title":"Characteristics, outcome, and care of stroke associated with atrial fibrillation in Europe: data from a multicenter multinational hospital-based registry (The European Community Stroke Project)","volume":"32","author":"Lamassa","year":"2001","journal-title":"Stroke"},{"key":"10.1016\/j.hfc.2019.08.007_bib7","doi-asserted-by":"crossref","first-page":"55","DOI":"10.2147\/CLEP.S4794","article-title":"Atrial fibrillation in patients with ischemic stroke: A population-based study","volume":"1","author":"Thygesen","year":"2009","journal-title":"Clin Epidemiol"},{"year":"1914","series-title":"Disease of the heart","author":"Mackenzie","key":"10.1016\/j.hfc.2019.08.007_bib8"},{"issue":"2","key":"10.1016\/j.hfc.2019.08.007_bib9","doi-asserted-by":"crossref","first-page":"3133","DOI":"10.3390\/ijms16023133","article-title":"Heart failure and atrial fibrillation: from basic science to clinical practice","volume":"16","author":"Ferreira","year":"2015","journal-title":"Int J Mol Sci"},{"issue":"5","key":"10.1016\/j.hfc.2019.08.007_bib10","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1161\/CIRCULATIONAHA.115.018614","article-title":"Atrial fibrillation begets heart failure and vice versa: temporal associations and differences in preserved versus reduced ejection fraction","volume":"133","author":"Santhanakrishnan","year":"2016","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.hfc.2019.08.007_bib11","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/nrcardio.2015.191","article-title":"Comorbidity of atrial fibrillation and heart failure","volume":"13","author":"Ling","year":"2016","journal-title":"Nat Rev Cardiol"},{"issue":"12","key":"10.1016\/j.hfc.2019.08.007_bib12","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1055\/s-0038-1675400","article-title":"Predicting thromboembolic and bleeding event risk in patients with non-valvular atrial fibrillation: a systematic review","volume":"118","author":"Borre","year":"2018","journal-title":"Thromb Haemost"},{"issue":"6","key":"10.1016\/j.hfc.2019.08.007_bib13","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003336.pub2","article-title":"Anticoagulation versus placebo for heart failure in sinus rhythm","author":"Lip","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"10.1016\/j.hfc.2019.08.007_bib14","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1378\/chest.09-1584","article-title":"Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation","volume":"137","author":"Lip","year":"2010","journal-title":"Chest"},{"issue":"5","key":"10.1016\/j.hfc.2019.08.007_bib16","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.chest.2018.07.040","article-title":"Antithrombotic therapy for atrial fibrillation: CHEST guideline and expert panel report","volume":"154","author":"Lip","year":"2018","journal-title":"Chest"},{"issue":"12","key":"10.1016\/j.hfc.2019.08.007_bib17","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1055\/s-0038-1676074","article-title":"Optimizing stroke and bleeding risk assessment in patients with atrial fibrillation: a balance of evidence, practicality and precision","volume":"118","author":"Proietti","year":"2018","journal-title":"Thromb Haemost"},{"issue":"38","key":"10.1016\/j.hfc.2019.08.007_bib18","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1093\/eurheartj\/ehw210","article-title":"2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS","volume":"37","author":"Kirchhof","year":"2016","journal-title":"Eur Heart J"},{"issue":"27","key":"10.1016\/j.hfc.2019.08.007_bib19","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","volume":"37","author":"Ponikowski","year":"2016","journal-title":"Eur Heart J"},{"issue":"7","key":"10.1016\/j.hfc.2019.08.007_bib20","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1136\/hrt.2007.140640","article-title":"Atrial fibrillation in heart failure: the chicken or the egg?","volume":"95","author":"Balasubramaniam","year":"2009","journal-title":"Heart"},{"issue":"4","key":"10.1016\/j.hfc.2019.08.007_bib21","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/S0735-1097(97)00254-4","article-title":"Hemodynamic effects of an irregular sequence of ventricular cycle lengths during atrial fibrillation","volume":"30","author":"Clark","year":"1997","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.hfc.2019.08.007_bib22","first-page":"751","article-title":"Atrial fibrillation and heart failure: a review of the intersection of two cardiac epidemics","volume":"6","author":"Lee Park","year":"2013","journal-title":"J\u00a0Atrial Fibrillation"},{"issue":"4","key":"10.1016\/j.hfc.2019.08.007_bib23","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0735-1097(96)00592-X","article-title":"Tachycardia-induced cardiomyopathy: a review of animal models and clinical studies","volume":"29","author":"Shinbane","year":"1997","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"23","key":"10.1016\/j.hfc.2019.08.007_bib24","doi-asserted-by":"crossref","first-page":"2920","DOI":"10.1161\/01.CIR.0000072767.89944.6E","article-title":"Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham Heart Study","volume":"107","author":"Wang","year":"2003","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.hfc.2019.08.007_bib25","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1177\/107424840300800203","article-title":"Heart failure complicated by atrial fibrillation: mechanistic, prognostic, and therapeutic implications","volume":"8","author":"Gronefeld","year":"2003","journal-title":"J\u00a0Cardiovasc Pharmacol Ther"},{"issue":"8","key":"10.1016\/j.hfc.2019.08.007_bib26","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1093\/eurheartj\/ehi694","article-title":"Incidence and mortality risk of congestive heart failure in atrial fibrillation patients: a community-based study over two decades","volume":"27","author":"Miyasaka","year":"2006","journal-title":"Eur Heart J"},{"issue":"2","key":"10.1016\/j.hfc.2019.08.007_bib27","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1161\/CIRCHEARTFAILURE.114.001667","article-title":"Left atrial remodeling and function in advanced heart failure with preserved or reduced ejection fraction","volume":"8","author":"Melenovsky","year":"2015","journal-title":"Circ Heart Fail"},{"issue":"23","key":"10.1016\/j.hfc.2019.08.007_bib28","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1161\/CIRCULATIONAHA.110.011031","article-title":"Prevalence and significance of alterations in cardiac structure and function in patients with heart failure and a preserved ejection fraction","volume":"124","author":"Zile","year":"2011","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.hfc.2019.08.007_bib29","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1161\/CIRCHEARTFAILURE.113.000887","article-title":"Cardiac structure and function in heart failure with preserved ejection fraction: baseline findings from the echocardiographic study of the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist trial","volume":"7","author":"Shah","year":"2014","journal-title":"Circ Heart Fail"},{"issue":"3","key":"10.1016\/j.hfc.2019.08.007_bib30","first-page":"e45","article-title":"Left atrial size and force in patients with systolic chronic heart failure: Comparison with healthy controls and different cardiac diseases","volume":"15","author":"Cioffi","year":"2010","journal-title":"Exp Clin Cardiol"},{"issue":"1","key":"10.1016\/j.hfc.2019.08.007_bib31","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/nrcardio.2016.163","article-title":"Neurohormonal activation in heart failure with reduced ejection fraction","volume":"14","author":"Hartupee","year":"2017","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.hfc.2019.08.007_bib32","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ijcard.2015.07.028","article-title":"Impact of atrial fibrillation ablation on cardiac sympathetic nervous system in patients with and without heart failure","volume":"199","author":"Masuda","year":"2015","journal-title":"Int J Cardiol"},{"issue":"11","key":"10.1016\/j.hfc.2019.08.007_bib33","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1161\/CIRCRESAHA.114.302589","article-title":"The autonomic nervous system and heart failure","volume":"114","author":"Florea","year":"2014","journal-title":"Circ Res"},{"issue":"30","key":"10.1016\/j.hfc.2019.08.007_bib34","doi-asserted-by":"crossref","first-page":"1982b","DOI":"10.1093\/eurheartj\/ehv087","article-title":"The sympathetic\/parasympathetic imbalance in heart failure with reduced ejection fraction","volume":"36","author":"Floras","year":"2015","journal-title":"Eur Heart J"},{"issue":"3","key":"10.1016\/j.hfc.2019.08.007_bib35","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1161\/CIRCEP.110.959650","article-title":"Autonomic remodeling in the left atrium and pulmonary veins in heart failure: creation of a dynamic substrate for atrial fibrillation","volume":"4","author":"Ng","year":"2011","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"1","key":"10.1016\/j.hfc.2019.08.007_bib36","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.amjms.2016.06.016","article-title":"Pathophysiologic mechanisms in heart failure: role of the sympathetic nervous system","volume":"353","author":"Antoine","year":"2017","journal-title":"Am J Med Sci"},{"issue":"8","key":"10.1016\/j.hfc.2019.08.007_bib37","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1161\/CIRCRESAHA.116.306082","article-title":"Microdomain switch of cGMP-regulated phosphodiesterases leads to ANP-induced augmentation of \u03b2-adrenoceptor-stimulated contractility in early cardiac hypertrophy","volume":"116","author":"Perera","year":"2015","journal-title":"Circ Res"},{"issue":"1","key":"10.1016\/j.hfc.2019.08.007_bib38","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1093\/cvr\/cvy272","article-title":"The prothrombotic state in atrial fibrillation: pathophysiological and management implications","volume":"115","author":"Khan","year":"2019","journal-title":"Cardiovasc Res"},{"issue":"9658","key":"10.1016\/j.hfc.2019.08.007_bib39","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0140-6736(09)60040-4","article-title":"Mechanisms of thrombogenesis in atrial fibrillation: Virchow's triad revisited","volume":"373","author":"Watson","year":"2009","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.hfc.2019.08.007_bib40","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/eurheartj\/14.2.205","article-title":"Platelet function, thrombin and fibrinolytic activity in patients with heart failure","volume":"14","author":"Jafri","year":"1993","journal-title":"Eur Heart J"},{"issue":"6","key":"10.1016\/j.hfc.2019.08.007_bib41","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1253\/jcj.64.411","article-title":"Prediction of embolism in atrial fibrillation: classification of left atrial thrombi by transesophageal echocardiography","volume":"64","author":"Abe","year":"2000","journal-title":"Jpn Circ J"},{"issue":"8986","key":"10.1016\/j.hfc.2019.08.007_bib42","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1016\/S0140-6736(95)92339-X","article-title":"Does atrial fibrillation confer a hypercoagulable state?","volume":"346","author":"Lip","year":"1995","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.hfc.2019.08.007_bib43","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1136\/hrt.73.6.527","article-title":"Increased markers of thrombogenesis in chronic atrial fibrillation: effects of warfarin treatment","volume":"73","author":"Lip","year":"1995","journal-title":"Br Heart J"},{"issue":"12","key":"10.1016\/j.hfc.2019.08.007_bib44","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1160\/TH17-08-0555","article-title":"Regional differences in antithrombotic treatment for atrial fibrillation: insights from the GLORIA-AF phase II registry","volume":"117","author":"Mazurek","year":"2017","journal-title":"Thromb Haemost"},{"issue":"11","key":"10.1016\/j.hfc.2019.08.007_bib45","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1002\/ejhf.645","article-title":"Global left atrial failure in heart failure","volume":"18","author":"Triposkiadis","year":"2016","journal-title":"Eur J Heart Fail"},{"issue":"2","key":"10.1016\/j.hfc.2019.08.007_bib46","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1161\/CIRCHEARTFAILURE.111.965681","article-title":"Presence of atrial fibrillation is independently associated with adverse outcomes in patients hospitalized with heart failure: an analysis of get with the guidelines-heart failure","volume":"5","author":"Mountantonakis","year":"2012","journal-title":"Circ Heart Fail"},{"issue":"7","key":"10.1016\/j.hfc.2019.08.007_bib47","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1093\/eurjhf\/hfp085","article-title":"A\u00a0meta-analysis of the prognostic significance of atrial fibrillation in chronic heart failure","volume":"11","author":"Mamas","year":"2009","journal-title":"Eur J Heart Fail"},{"issue":"5","key":"10.1016\/j.hfc.2019.08.007_bib48","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/j.1445-5994.2009.01991.x","article-title":"Atrial fibrillation and the risk of death in patients with heart failure: a literature-based meta-analysis","volume":"40","author":"Wasywich","year":"2010","journal-title":"Intern Med J"},{"issue":"45","key":"10.1016\/j.hfc.2019.08.007_bib49","doi-asserted-by":"crossref","first-page":"e13074","DOI":"10.1097\/MD.0000000000013074","article-title":"Clinical characteristics and thromboembolic risk of atrial fibrillation patients with and without congestive heart failure. Results from the CRATF study","volume":"97","author":"Balsam","year":"2018","journal-title":"Medicine (Baltimore)"},{"issue":"10","key":"10.1016\/j.hfc.2019.08.007_bib50","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1001\/jama.2015.10725","article-title":"Assessment of the CHA2DS2-VASc score in predicting ischemic stroke, thromboembolism, and death in patients with heart failure with and without atrial fibrillation","volume":"314","author":"Melgaard","year":"2015","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.hfc.2019.08.007_bib51","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1378\/chest.10-0134","article-title":"A\u00a0novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey","volume":"138","author":"Pisters","year":"2010","journal-title":"Chest"},{"issue":"9","key":"10.1016\/j.hfc.2019.08.007_bib52","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1111\/jth.13386","article-title":"Bleeding risk assessment in atrial fibrillation: observations on the use and misuse of bleeding risk scores","volume":"14","author":"Lip","year":"2016","journal-title":"J\u00a0Thromb Haemost"},{"issue":"5","key":"10.1016\/j.hfc.2019.08.007_bib53","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1160\/TH13-07-0552","article-title":"Comparison of the CHADS2, CHA2DS2-VASc and HAS-BLED scores for the prediction of clinically relevant bleeding in anticoagulated patients with atrial fibrillation: the AMADEUS trial","volume":"110","author":"Apostolakis","year":"2013","journal-title":"Thromb Haemost"},{"issue":"4","key":"10.1016\/j.hfc.2019.08.007_bib54","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s00380-017-1073-5","article-title":"Thromboembolisms in atrial fibrillation and heart failure patients with a preserved ejection fraction (HFpEF) compared to those with a reduced ejection fraction (HFrEF)","volume":"33","author":"Sobue","year":"2018","journal-title":"Heart Vessels"},{"issue":"19","key":"10.1016\/j.hfc.2019.08.007_bib55","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1093\/eurheartj\/eht066","article-title":"Incidence and epidemiology of new onset heart failure with preserved vs. reduced ejection fraction in a community-based cohort: 11-year follow-up of PREVEND","volume":"34","author":"Brouwers","year":"2013","journal-title":"Eur Heart J"},{"issue":"10","key":"10.1016\/j.hfc.2019.08.007_bib56","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1161\/CIRCULATIONAHA.113.001475","article-title":"Temporal relationship and prognostic significance of atrial fibrillation in heart failure patients with preserved ejection fraction: a community-based study","volume":"128","author":"Zakeri","year":"2013","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.hfc.2019.08.007_bib57","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.jchf.2017.05.001","article-title":"Atrial fibrillation in heart failure with preserved, mid-range, and reduced ejection fraction","volume":"5","author":"Sartipy","year":"2017","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.hfc.2019.08.007_bib58","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.ijcard.2018.04.093","article-title":"Heart failure subtypes and thromboembolic risk in patients with atrial fibrillation: The PREFER in AF-HF substudy","volume":"265","author":"Siller-Matula","year":"2018","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.hfc.2019.08.007_bib59","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.ijcard.2015.10.220","article-title":"Atrial fibrillation and heart failure due to reduced versus preserved ejection fraction: a systematic review and meta-analysis of death and adverse outcomes","volume":"203","author":"Kotecha","year":"2016","journal-title":"Int J Cardiol"},{"issue":"48","key":"10.1016\/j.hfc.2019.08.007_bib60","doi-asserted-by":"crossref","first-page":"4277","DOI":"10.1093\/eurheartj\/ehy626","article-title":"Prognostic implications of atrial fibrillation in heart failure with reduced, mid-range, and preserved ejection fraction: a report from 14\u2009964 patients in the European Society of Cardiology Heart Failure Long-Term Registry","volume":"39","author":"Zafrir","year":"2018","journal-title":"Eur Heart J"},{"issue":"suppl_1","key":"10.1016\/j.hfc.2019.08.007_bib61","article-title":"Systematic review of atrial fibrillation and stroke in patients with hypertrophic cardiomyopathy","volume":"34","author":"Guttmann","year":"2013","journal-title":"Eur Heart J"},{"issue":"2","key":"10.1016\/j.hfc.2019.08.007_bib62","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1055\/s-0038-1676818","article-title":"Hypertrophic cardiomyopathy in patients with atrial fibrillation: prevalence and associated stroke risks in a nationwide cohort study","volume":"119","author":"Jung","year":"2019","journal-title":"Thromb Haemost"},{"issue":"3","key":"10.1016\/j.hfc.2019.08.007_bib63","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1055\/s-0039-1678724","article-title":"Atrial fibrillation and stroke in patients with hypertrophic cardiomyopathy: important new insights","volume":"119","author":"Borer","year":"2019","journal-title":"Thromb Haemost"},{"issue":"12","key":"10.1016\/j.hfc.2019.08.007_bib64","doi-asserted-by":"crossref","first-page":"857","DOI":"10.7326\/0003-4819-146-12-200706190-00007","article-title":"Meta-analysis: antithrombotic therapy to prevent stroke in patients\u00a0who have nonvalvular atrial fibrillation","volume":"146","author":"Hart","year":"2007","journal-title":"Ann Intern\u00a0Med"},{"issue":"22","key":"10.1016\/j.hfc.2019.08.007_bib65","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1056\/NEJMoa1310907","article-title":"Edoxaban versus warfarin in patients with atrial fibrillation","volume":"369","author":"Giugliano","year":"2013","journal-title":"N\u00a0Engl J Med"},{"issue":"11","key":"10.1016\/j.hfc.2019.08.007_bib66","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1056\/NEJMoa1107039","article-title":"Apixaban versus warfarin in patients with atrial fibrillation","volume":"365","author":"Granger","year":"2011","journal-title":"N\u00a0Engl J Med"},{"issue":"10","key":"10.1016\/j.hfc.2019.08.007_bib67","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa1009638","article-title":"Rivaroxaban versus warfarin in nonvalvular atrial fibrillation","volume":"365","author":"Patel","year":"2011","journal-title":"N\u00a0Engl J Med"},{"issue":"12","key":"10.1016\/j.hfc.2019.08.007_bib68","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","article-title":"Dabigatran versus warfarin in patients with atrial fibrillation","volume":"361","author":"Connolly","year":"2009","journal-title":"N\u00a0Engl J Med"},{"issue":"11","key":"10.1016\/j.hfc.2019.08.007_bib69","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1002\/ejhf.343","article-title":"Non-vitamin K antagonist oral anticoagulants (NOACs) in patients with concomitant atrial fibrillation and heart failure: a systemic review and meta-analysis of randomized trials","volume":"17","author":"Xiong","year":"2015","journal-title":"Eur J Heart Fail"},{"issue":"3","key":"10.1016\/j.hfc.2019.08.007_bib70","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1161\/CIRCHEARTFAILURE.112.000143","article-title":"Left ventricular systolic dysfunction, heart failure, and the risk of stroke and systemic embolism in patients with atrial fibrillation: insights from the ARISTOTLE trial","volume":"6","author":"McMurray","year":"2013","journal-title":"Circ Heart Fail"},{"issue":"11","key":"10.1016\/j.hfc.2019.08.007_bib71","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.jchf.2016.07.012","article-title":"Efficacy and safety of novel oral anticoagulants in patients with atrial fibrillation and heart failure: a meta-analysis","volume":"4","author":"Savarese","year":"2016","journal-title":"JACC Heart Fail"},{"issue":"9","key":"10.1016\/j.hfc.2019.08.007_bib72","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1002\/ejhf.595","article-title":"Efficacy and safety of edoxaban compared with warfarin in patients with atrial fibrillation and heart failure: insights from ENGAGE AF-TIMI 48","volume":"18","author":"Magnani","year":"2016","journal-title":"Eur J Heart Fail"},{"issue":"12","key":"10.1016\/j.hfc.2019.08.007_bib73","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1586\/erc.12.148","article-title":"New oral anticoagulants for stroke prevention in atrial fibrillation: impact of gender, heart failure, diabetes mellitus and paroxysmal atrial fibrillation","volume":"10","author":"Ahmad","year":"2012","journal-title":"Expert Rev Cardiovasc Ther"},{"issue":"5","key":"10.1016\/j.hfc.2019.08.007_bib74","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1007\/s00392-014-0797-9","article-title":"Renal function and non-vitamin K oral anticoagulants in comparison with warfarin on safety and efficacy outcomes in atrial fibrillation patients: a systemic review and meta-regression analysis","volume":"104","author":"Nielsen","year":"2015","journal-title":"Clin Res Cardiol"},{"issue":"2","key":"10.1016\/j.hfc.2019.08.007_bib75","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.chest.2018.11.009","article-title":"Effectiveness and safety of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation with hypertrophic cardiomyopathy: a nationwide cohort study","volume":"155","author":"Jung","year":"2019","journal-title":"Chest"}],"container-title":["Heart Failure Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551713619300911?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551713619300911?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T08:39:35Z","timestamp":1761554375000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1551713619300911"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":74,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["S1551713619300911"],"URL":"https:\/\/doi.org\/10.1016\/j.hfc.2019.08.007","relation":{},"ISSN":["1551-7136"],"issn-type":[{"type":"print","value":"1551-7136"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Atrial Fibrillation in Heart Failure","name":"articletitle","label":"Article Title"},{"value":"Heart Failure Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hfc.2019.08.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}